Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toffoli

Showing results (491-500 of 782) with videos related to

Pageof 79
Sort By:
Nanomaterials (Basel, Switzerland)|September 3, 2020
Fluorescent Imprinted Nanoparticles for the Effective Monitoring of Irinotecan in Human PlasmaMartina Tommasini, Elena Pellizzoni, Valentina Iacuzzi, et al.
World Journal of Gastroenterology|September 22, 2017
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsGuido Giordano, Massimo Pancione, Nunzio Olivieri, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 3, 2021
Macrophage activation in vitro by Parachartergus fraternus venomJéssica de Araujo Isaias Muller, Joyce Dos Santos Lencina, Maria Inês Lenz Souza, et al.
Pharmaceutics|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug MonitoringGiovanni Canil, Marco Orleni, Bianca Posocco, et al.
Human Genomics|November 10, 2023
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicityElena De Mattia, Jerry Polesel, Marco Silvestri, et al.
Cancers|October 18, 2019
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine LearningMaurizio Polano, Marco Chierici, Michele Dal Bo, et al.
International Journal of Clinical Oncology|June 7, 2012
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patientsSergio Frustaci, Angela Buonadonna, Elisa Turchet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patientsG Toffoli, R Sorio, P Aita, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 1, 2019
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routineElena Marangon, Mauro Buzzo, Bianca Posocco, et al.
Biomed Research International|July 23, 2014
Correlation between density and resorption of fresh-frozen and autogenous bone graftsSimone Lumetti, Carlo Galli, Edoardo Manfredi, et al.
Pageof 79

Showing results (491-500 of 782) with videos related to

Sort By:
Pageof 79
Nanomaterials (Basel, Switzerland)|September 3, 2020
Fluorescent Imprinted Nanoparticles for the Effective Monitoring of Irinotecan in Human PlasmaMartina Tommasini, Elena Pellizzoni, Valentina Iacuzzi, et al.
World Journal of Gastroenterology|September 22, 2017
Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directionsGuido Giordano, Massimo Pancione, Nunzio Olivieri, et al.
Toxicon : Official Journal of the International Society on Toxinology|May 3, 2021
Macrophage activation in vitro by Parachartergus fraternus venomJéssica de Araujo Isaias Muller, Joyce Dos Santos Lencina, Maria Inês Lenz Souza, et al.
Pharmaceutics|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug MonitoringGiovanni Canil, Marco Orleni, Bianca Posocco, et al.
Human Genomics|November 10, 2023
The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicityElena De Mattia, Jerry Polesel, Marco Silvestri, et al.
Cancers|October 18, 2019
A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine LearningMaurizio Polano, Marco Chierici, Michele Dal Bo, et al.
International Journal of Clinical Oncology|June 7, 2012
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patientsSergio Frustaci, Angela Buonadonna, Elisa Turchet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Dose-finding and pharmacologic study of chronic oral idarubicin therapy in metastatic breast cancer patientsG Toffoli, R Sorio, P Aita, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 1, 2019
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routineElena Marangon, Mauro Buzzo, Bianca Posocco, et al.
Biomed Research International|July 23, 2014
Correlation between density and resorption of fresh-frozen and autogenous bone graftsSimone Lumetti, Carlo Galli, Edoardo Manfredi, et al.
Pageof 79